Commentary

The art of self-governance

There’s reasons on all sides to settle on market practice when it comes to continuation vehicle guidance – lest regulators decide it for you.

Secondaries may have a benchmarking problem

The lack of standardisation when it comes to benchmarking secondaries raises questions about how the strategy should be measured and whether traditional PE benchmarks are a good fit.

Achieving scale in infra secondaries

The sub-asset class has been described as one of the most undercapitalised private market strategies – while estimates for future growth are high, there are structural elements to consider.

Secondaries’ superstars

Secondaries Investor’s Next Gen Leaders list 2026 will provide clues about the future of the market’s growth.

CVs’ about-turn

Some LPs have expressed scepticism around the return potential of LP-led secondaries, while interest in CVs is heating up.

In defence of valuations

Senior execs have been working to spell out why secondaries mark-up practices make sense following public scepticism from peers.

Is UK regulatory scrutiny a competitive disadvantage for secondaries deals?

The real challenge appears operational rather than structural from a geographical standpoint, writes Winston & Strawn’s Yulia Makarova.

The CV blueprint expands

Secondaries Investor’s latest CV deal log shows activity broadening across segments, transaction types and asset classes.

Pantheon’s Hassanally: Debut CFO unlocks secondaries for constricted investors

The manager’s $1bn CFO created access for insurance investors that had lost the ability to back PE, while offering a compelling capital raising strategy for the firm itself.

The cost of doing business

Lazard’s acquisition of Campbell Lutyens proves scale matters. While there’s room at the top for more players, success will come with a price tag.